Sands, B. E., Feagan, B. G., Sandborn, W. J., Shipitofsky, N., Marko, M., Sheng, S., Johanns, J., Germinaro, M., Vetter, M., & Panés, J. (n.d.). oP36 Efficacy and safety of combination induction therapy with guselkumab and golimumab in participants with moderately-to-severely active Ulcerative Colitis: Results through week 12 of a phase 2a randomized, double-blind, active-controlled, parallel-group, multicenter, proof-of-concept study. Journal of Crohn's and colitis, 16, i042–i043. http://access.bl.uk/ark:/81055/vdc_100150514992.0x00000c